GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Noile-Immune Biotech Inc (TSE:4893) » Definitions » Other Stockholders Equity

Noile-Immune Biotech (TSE:4893) Other Stockholders Equity : 円6.8 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Noile-Immune Biotech Other Stockholders Equity?

Noile-Immune Biotech's Other Stockholders Equity for the quarter that ended in Mar. 2024 was 円6.8 Mil.

Noile-Immune Biotech's quarterly Other Stockholders Equity stayed the same from Sep. 2023 (円6.9 Mil) to Dec. 2023 (円6.9 Mil) but then declined from Dec. 2023 (円6.9 Mil) to Mar. 2024 (円6.8 Mil).

Noile-Immune Biotech's annual Other Stockholders Equity increased from Dec. 2021 (円5.1 Mil) to Dec. 2022 (円6.9 Mil) and increased from Dec. 2022 (円6.9 Mil) to Dec. 2023 (円6.9 Mil).


Noile-Immune Biotech Other Stockholders Equity Historical Data

The historical data trend for Noile-Immune Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noile-Immune Biotech Other Stockholders Equity Chart

Noile-Immune Biotech Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
5.06 5.06 6.90 6.90

Noile-Immune Biotech Quarterly Data
Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only - 6.90 6.90 6.90 6.85

Noile-Immune Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Noile-Immune Biotech Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Noile-Immune Biotech's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Noile-Immune Biotech (TSE:4893) Business Description

Traded in Other Exchanges
N/A
Address
2-12-10 Shiba-Daimon, Minato-ku, Tokyo, JPN, 105-0012
Noile-Immune Biotech Inc is engaged in the development of novel cancer immunotherapy including CAR-T cell therapy.

Noile-Immune Biotech (TSE:4893) Headlines

No Headlines